Nobis Nobis Cartel windows 7 home premium activation key 70-290

Childhood pemphigus vulgaris successfully treated with rituximab

Pemphigus is a potentially fatal autoimmune epidermal bullous disorder. Rituximab is a novel therapy for the treatment of refractory pemphigus. However, there is limited clinical data on safety and efficacy of rituximab in pediatric age group. Herein, we report an 11-year-old boy of childhood pemphigus vulgaris who failed to respond to dexamethasone pulse therapy and was subsequently treated with rituximab and achieved complete remission.

http://www.ijdvl.com/article.asp?issn=0378-6323;year=2012;volume=78;issue=5;spage=632;epage=634;aulast=Kanwar

Getagd met , ,
Geplaatst in Around the Globe, News and Information

JOIN TODAY!

The P/P Registry has been approved by the Western Institutional Review Board (WIRB) and is actively enrolling participants.

ENGLISH VERSION